Pinkerton Mac S
Known title: Pres. of North America Trans.CIK: 0001763184
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Texas Judge Upholds Nuclear Verdict Against C.H. Robinson. A Texas judge has upheld a nuclear liability verdict against C.H. Robinson. The decision could increase the company's legal costs and affect its financial outlook. The verdict highlights the risks associated with the company's freight and logistics operations. Investors may watch how the company responds to the judgment.
Transaction History
| ARCB | ▲ Buy | Grant | 2,150 | $0 | 2/6/2026 | View on chart |
| CHRW | ▲ Buy | Option Exercise | 7,624 | $444K | 5/1/2023 | View on chart |
| CHRW | ▼ Sell | Open Market | 7,624 | $774K | 5/1/2023 | View on chart |
| CHRW | ▼ Sell | Tax Withholding | 793 | $83K | 2/15/2023 | View on chart |
| CHRW | ▲ Buy | Grant | 9,190 | $0 | 2/8/2023 | View on chart |
| CHRW | ▲ Buy | Grant | 3,362 | $0 | 2/8/2023 | View on chart |
| CHRW | ▲ Buy | Grant | 9,670 | $0 | 2/8/2023 | View on chart |
| CHRW | ▲ Buy | Grant | 2,755 | $0 | 2/1/2023 | View on chart |
| CHRW | ▲ Buy | Option Exercise | 4,241 | $247K | 5/25/2022 | View on chart |
| CHRW | ▲ Buy | Option Exercise | 956 | $59K | 5/25/2022 | View on chart |
| CHRW | ▼ Sell | Open Market | 4,241 | $449K | 5/25/2022 | View on chart |
| CHRW | ▼ Sell | Tax Withholding | 892 | $80K | 2/15/2022 | View on chart |
| CHRW | ▲ Buy | Grant | 1,586 | $0 | 2/9/2022 | View on chart |
| CHRW | ▲ Buy | Grant | 10,630 | $0 | 2/9/2022 | View on chart |
| CHRW | ▲ Buy | Grant | 14,218 | $0 | 2/2/2022 | View on chart |
| CHRW | ▲ Buy | Option Exercise | 4,993 | $344K | 11/18/2021 | View on chart |
| CHRW | ▼ Sell | Open Market | 540 | $51K | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ArcBest Unveils New View Features Amid Earnings Outlook
ArcBest has introduced new features in its ArcBest View platform, expanding its digital offerings. Analysts are debating whether the company will exceed earnings expectations in the next report, while some reports highlight potential drawbacks. The stock sits near a key support level and its RSI is in a neutral zone, reflecting a balanced market view.
ArcBest Unveils New View Features Amid Earnings Outlook. ArcBest has introduced new features in its ArcBest View platform, expanding its digital offerings. Analysts are debating whether the company will exceed earnings expectations in the next report, while some reports highlight potential drawbacks. The stock sits near a key support level and its RSI is in a neutral zone, reflecting a balanced market view.